Home Stakeholders Health & Social Care Stakeholders The EU Joint Programme – Neurodegenerative Disease Research (JPND)

The EU Joint Programme – Neurodegenerative Disease Research (JPND)

JPND – finding cures for neurodegenerative diseases and working to enable early diagnosis for early targeted treatments with worldwide collaboration

The EU Joint Programme – Neurodegenerative Disease Research (JPND) is the largest global research initiative aimed at tackling the challenge of neurodegenerative diseases.

The ultimate goal of JPND is to find cures for neurodegenerative diseases and to enable early diagnosis for early targeted treatments. Originally a European member-state-led initiative, JPND is today a global initiative with 30 participating countries[1].

JPND aims to confront the growing challenge posed by neurodegenerative diseases in our ageing population by bringing together researchers, leveraging on existing research evidence and national funding bodies to investigate the key research domains and barriers, to accelerate progress in this area. It aims to increase coordinated investment between participating countries in research focused on finding causes, developing cures, and identifying appropriate ways to care for those with neurodegenerative diseases. JPND has an ongoing programme of actions encouraging participating countries to agree on research strategies to tackle neurodegenerative diseases at their own national level also.

JPND members share a common Research and Innovation Strategy (RIS) that provides a roadmap for investment in research to improve prevention, diagnosis, treatment and patient care for neurodegenerative diseases. This RIS has been updated in 2019. It builds on and updates the framework set out in the original Research Strategy that was released in 2012 to ensure that it continues to have impact in the research community and among policymakers.

Finding new treatments that cure the diseases take time, many researchers and large funding. Even in a favourable context, it is not possible to give definitive predictions on how long this might take to happen. In the interim, JPND has identified through its RIS common research goals that would benefit from joint action between countries, in order to accelerate progress in solutions that can alleviate the symptoms, and lessen the social and economic impact for patients, families and health care systems.

Only by maximising our collective potential can the global challenge of neurodegenerative diseases and more generally of brain health be confronted.


[1] These include twenty-three EU Member States (Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Luxembourg, Netherlands, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, United Kingdom)  four Associated Countries (Albania, Israel, Norway and Turkey) and three Partner Countries (Australia, Canada and Switzerland). In 2018, a collaboration with the National Institute of Ageing (NIH) in the US was realised which will be renewed in 2020. In its continuing efforts of global outreach and in addition to more actively engaging non-EU countries around Europe, JPND also extends its outreach initiatives to Asia.


US Election 2020

Stakeholder Profiles